Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

著者: Jeffrey D. Whitman, Joseph Hiatt, Cody T. Mowery, Brian R. Shy, Ruby Yu, Tori N. Yamamoto, Ujjwal Rathore, Gregory M. Goldgof, Caroline Whitty, Jonathan M. Woo, Antonia E. Gallman, Tyler E. Miller, Andrew G. Levine, David N. Nguyen, Sagar P. Bapat, Joanna Balcerek, Sophia Bylsma, Ana M. Lyons, Stacy Li, Allison W. Wong, Eva Mae Gillis-Buck, Zachary Steinhart, Youjin Lee, Ryan Apathy, Mitchell J. Lipke, Jennifer A. Smith, Tina Zheng, Ian C. Boothby, Erin Isaza, Jackie Chan, Dante Acenas, Jinwoo Lee, Trisha A. Macrae, Than S. Kyaw, David Wu, Dianna Ng, Wei Gu, Vanessa A. York, Haig Alexander Eskandarian, Perri C. Callaway, Lakshmi Warrier, Mary E. Moreno, Justine Levan, Leonel Torres, Lila A. Farrington, Rita P. Loudermilk, Kanishka Koshal, Kelsey C. Zorn, Wilfredo F. García-Beltrán, Diane Yang, Michael G. Astudillo, B Bernstein, Jeffrey A. Gelfand, Edward T. Ryan, Richelle C. Charles, A. John Iafrate, Jochen K. Lennerz, Steve Miller, Charles Y. Chiu, Susan L. Stramer, Michael R. Wilson, Aashish Manglik, Chun Ye, Nevan J. Krogan, Mark S. Anderson, Jason G. Cyster, J. Ernst, Alan H.B. Wu, Kara L. Lynch, Caryn Bern, Patrick D. Hsu, Alexander Marson - Nature Biotechnology 2020 被引用: 299